STK-012

· Synthekine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STK-012, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers [Phase 1, Phase 2]

See pricing